Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Êîñìåòîëîãèÿ-äåðìàòîëîãèÿ > Ãåðïåñ - äèàãíîñòèêà è ëå÷åíèå

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 12.02.2011, 15:44
Àâàòàð äëÿ CuriousMasha
CuriousMasha CuriousMasha âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.03.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 29
Ñêàçàë(à) ñïàñèáî: 3
CuriousMasha *
Exclamation Ìîæíî ëè áåðåìåíåòü íà ôîíå Âàëòðåêñà? È ñðàçó áðîñèòü ïðèåì, êàê òîëüêî?

Çäðàâñòâóéòå,
ÿ çàðàçèëàñü Ãà ïîëòîðà ãîäà íàçàä. Îáîñòðåíèÿ áûëè ÷àñòûìè, ôàêòè÷åñêè ïîñëå êàæäîãî ïîëîâîãî àêòà, êîòîðûé ñîáñòâåííî èõ è ïðîâîöèðîâàë. Ïðîòåêàëè áîëåçíåííî, ñ íåâðàëãèÿìè è äîëãî ïðîõîäèëè.
Íà ñóïðåññèâíóþ òåðàïèþ ðåøèëàñü íå ñðàçó, íî ïîòîì ïîíÿëà, ÷òî, êàê òîëüêî áðîñàþ ïèòü Âàëòðåêñ, âîçîáíîâëåíèå ïîëîâîé æèçíè íåìèíóåìî ïðèâîäèò ê îáîñòðåíèþ.

Ñåé÷àñ óæå 4 ìåñÿöà ïüþ Âàëòðåêñ êàæäûé äåíü (500 ìã). Îáîñòðåíèÿ ïðåêðàòèëèñü. Ïëàíèðóþ áåðåìåííîñòü. Íå çíàþ â ñâÿçè ñ ýòèì êàê ïîñòóïèòü ñî ñâîåé ñóïðåññèâíîé òåðàïèåé. Íå ôàêò, ÷òî ó ìåíÿ ïîëó÷èòñÿ çàáåðåìåíåòü ïðè ïåðâîé æå îâóëÿöèè (åñòü äðóãèå, íå èíôåêöèîííûå ïðîáëåìû ïî ÷àñòè ãèíåêîëîãèè), íî ïåðâûå æå ïîïûòêè çàáåðåìåíåòü áåç ôîíîâîé ïîääåðæêè âàëòðåêñîì, ìîãóò ïðèâåñòè ê îáîñòðåíèþ ÃÃ. À åñëè âèðóñ îïÿòü "ðàñêî÷åãàðèòñÿ" â ïîëíóþ ñèëó, ïîëîâóþ æèçíü ïðèäåòñÿ ïðåêðàòèòü - ñ âèðóñîì íåëüçÿ äîãîâîðèòüñÿ, ÷òîá îí íå áåñïîêîèë ìåíÿ õîòÿ áû íà âðåìÿ îâóëÿöèé. Ïîõîæå íà çàìêíóòûé êðóã

ß çíàþ, ÷òî âî âðåìÿ áåðåìåííîñòè íå ðåêîìåíäîâàíà òåðàïèÿ âàëòðåêñîì âïëîòü äî 36-îé íåäåëè. Íî ìîæíî ëè ïûòàòüñÿ çàáåðåìåíåòü íà ôîíå ñóïðåññèâíîé òåðàïèè è áðîñèòü âàëòðåêñ ñðàçó æå, êàê òîëüêî áåðåìåííîñòü ïîäòâåðäèòñÿ?

Äëÿ ìåíÿ ýòî áûëî áû íàñòîÿùèì âûõîäîì èç ïîëîæåíèÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 15.02.2011, 00:29
Dr.Anisimova Dr.Anisimova âíå ôîðóìà ÂÐÀ×
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 16.01.2007
Ãîðîä: ÐÔ
Ñîîáùåíèé: 14,319
Ñêàçàë(à) ñïàñèáî: 6
Ïîáëàãîäàðèëè 5,347 ðàç(à) çà 4,983 ñîîáùåíèé
Dr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
- îïûò íàêîïëåí ïî ïðèìåíåíèþ ïðåèìóùåñòâåííî àöèêëîâèðà âî âðåìÿ áåðåìåííîñòè, ïî âàëòðåêñó èíôîðìàöèè ìåíüøå;
- ÷èñëî îáîñòðåíèé â ãîä âíå ïðèåìà âàëòðåêñà? è ñêîëüêî ñåé÷àñ çà 4 ìåñ.?
- Âû ìîæåòå çàâåðøèòü ñóïðåññèâíóþ òåðàïèþ âàëòðåêñîì â òå÷åíèå ãîäà è óæå ïîñëå áåðåìåííîñòü, ïîòîìó êàê 4 ìåñ. äëÿ ñóïðåññèè ìàëî(ëó÷øå áåç ïðèåìà ïðåïàðàòà è òîëüêî ïî ïîêàçàíèÿì âî âðåìÿ áåðåìåííîñòè-íà ðåöèäèâ, íàïðèìåð, ëèáî ïåðåä ðîäàìè)
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 19.02.2011, 00:17
Àâàòàð äëÿ CuriousMasha
CuriousMasha CuriousMasha âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.03.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 29
Ñêàçàë(à) ñïàñèáî: 3
CuriousMasha *
Óâàæàåìàÿ Ìàðèÿ Þðüåâíà, ñïàñèáî çà îòâåò. Íî ÿ áû õîòåëà çàîñòðèòü ñâîé âîïðîñ. Îí îòëè÷àåòñÿ îò ïîõîæèõ âîïðîñîâ ïðî áåðåìåííîñòü è òàáëåòêè, êîòîðûå çäåñü ÷àñòî çàäàþò.

Äëÿ íà÷àëà îòâå÷ó íà âàøè óòî÷íÿþùèå âîïðîñû:
1) äî íà÷àëà ñóïðåññèè îáîñòðåíèÿ áûëè ÷àñòûìè: âñåðüåç ñ íåâðàëãèÿìè è ðåçÿìè âûñûïàëî ðàç â 1,5 ìåñÿöà, íî êàê ÿ óæå ãîâîðèëà, ëþáîé ïîëîâîé àêò ïðèâîäèë ê àêòèâèçàöèè âèðóñà â òîé èëè èíîé ñòåïåíè;
2) çà 4 ìåñÿöà ñóïðåññèè âûñûïàíèÿ áûëè òîëüêî â ïåðâûé ìåñÿö, ïîòîì ïðåêðàòèëèñü;
3) îòêëàäûâàòü ïîïûòêè çàáåðåìåíåòü åùå ìèíèìóì íà 6 ìåñÿöåâ, ÷òîáû âûäåðæàòü ãîä ñóïðåññèâíîé òåðàïèè, íå õîòåëîñü áû. Ìíå çà òðèäöàòü, ó ìåíÿ áûëè ýíäîìåòðèîèäíûå êèñòû, ïîñëå èõ óäàëåíèÿ ÿ ïðîøëà êóðñ çîëàäåêñà, è òåïåðü âðà÷è íàñòîÿòåëüíî ðåêîìåíäóþò ìíå ïîñïåøèòü ñ áåðåìåííîñòüþ: íåèçâåñòíî, êàê ïîâåäåò ñåáÿ ìîé ýíäîìåòðèîç â áóäóùåì...

À ÑÏÅÖÈÔÈÊÀ ÌÎÅÃÎ ÂÎÏÐÎÑÀ çàêëþ÷àåòñÿ âîò â ÷åì:
ÿ ïîíèìàþ, ÷òî ñóïðåññèÿ íå ðåêîìåíäóåòñÿ ïðè áåðåìåííîñòè, è íå ïëàíèðóþ ïðîäîëæàòü ñóïðåññèþ âî âðåìÿ áåðåìåííîñòè, íî â ìîåì ñëó÷àå îñíîâíûì ïðîâîêàòîðîì Ãà ÿâëÿåòñÿ èìåííî ïîëîâîé àêò: åñëè ÿ ïðåêðàùó åæåäíåâíî ïèòü ïðåïàðàò, ÷òîáû áåðåìåíåòü, âèðóñ ìîæåò îáîñòðèòüñÿ ñíîâà, è òîãäà ïðèäåòñÿ îñòàâèòü âñÿêèå äàëüíåéøèå ïîïûòêè (à ìíå âîçìîæíî ïîíàäîáèòñÿ íå îäíà îâóëÿöèÿ, ÷òîáû ó ìåíÿ ïîëó÷èëîñü).
ß áû õîòåëà ïèòü ïðåïàðàò åæåäíåâíî è ïûòàòüñÿ áåðåìåíåòü íà ôîíå ïðèåìà, è ÒÓÒ ÆÅ ÏÐÅÊÐÀÒÈÒÜ ÅÃÎ ÏÈÒÜ, ÊÀÊ ÒÎËÜÊÎ ÁÅÐÅÌÅÍÍÎÑÒÜ ÏÐÎÈÇÎÉÄÅÒ. Âåäü ÿ áóäó ñëåäèòü çà ýòèì, è ñàìîå áîëüøåå, òåðàïèÿ ìîæåò ñîâïàñòü òîëüêî ñ ïåðâîé íåäåëåé-äâóìÿ áåðåìåííîñòè, êîãäà ÿ åùå íå áóäó îá ýòîì çíàòü è áóäó ïðîäîëæàòü ïèòü òàáëåòêè, ÷òîáû îáåçîïàñèòü ñåáÿ îò ÃÃ íà ñëåäóþùóþ îâóëÿöèþ.

ÂÎÒ ×ÒÎ ÍÀ ÌÎÈÕ ÂÅÑÀÕ: âîçìîæíàÿ óãðîçà òîëüêî-òîëüêî çàðîäèâøåìóñÿ ïëîäó (îäíà-äâå íåäåëè) îò ïðèåìà ïðîòèâîâèðóñíîãî ïðåïàðàòà ÈËÈ óãðîçà àêòèâèçàöèè âèðóñà áåç ïîääåðæêè ïðåïàðàòîì â ïåðâûé æå äåíü îâóëÿöèè, èç-çà ÷åãî âñå ïîñëåäóþùèå ïîïûòêè ïðèäåòñÿ ïðåêðàòèòü.

ß ãîòîâà ñìåíèòü Âàëòðåêñ íà àöèêëîâèð, ïðîèçâîäèìûé êîìïàíèåé "ÃëàêñîÑìèòÊëÿéí" ïîä íàçâàíèåì "Çîâèðàêñ", êîòîðûé ñ÷èòàåòñÿ áîëåå ïðîâåðåííûì èñïûòàíèÿìè íà ïåðèîä áåðåìåííîñòè: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Çàðàíåå ñïàñèáî çà äîïîëíèòåëüíûå ðàçúÿñíåíèÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 22.02.2011, 00:22
Dr.Anisimova Dr.Anisimova âíå ôîðóìà ÂÐÀ×
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 16.01.2007
Ãîðîä: ÐÔ
Ñîîáùåíèé: 14,319
Ñêàçàë(à) ñïàñèáî: 6
Ïîáëàãîäàðèëè 5,347 ðàç(à) çà 4,983 ñîîáùåíèé
Dr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ÂÎÒ ×ÒÎ ÍÀ ÌÎÈÕ ÂÅÑÀÕ: âîçìîæíàÿ óãðîçà òîëüêî-òîëüêî çàðîäèâøåìóñÿ ïëîäó (îäíà-äâå íåäåëè) îò ïðèåìà ïðîòèâîâèðóñíîãî ïðåïàðàòà ÈËÈ óãðîçà àêòèâèçàöèè âèðóñà áåç ïîääåðæêè ïðåïàðàòîì â ïåðâûé æå äåíü îâóëÿöèè, èç-çà ÷åãî âñå ïîñëåäóþùèå ïîïûòêè ïðèäåòñÿ ïðåêðàòèòü.- íå âñå ó÷ëè, íà âåñàõ íå òîëüêî ýòî, íî è
- äà, è çäåñü ñî ñòîðîíû ìåäèöèíû ó Âàñ óæå åñòü âñå äàííûå, à âîïðîñ ïî ëè÷íîìó âûáîðó óæå òîëüêî çà Âàìè
+ åùå âàæíûé ìîìåíò, ÷òî ïîñëå ãîäà ñóïðåññèâíîé òåðàïèè âåðîÿòíîñòü, ÷òî öèñëî ðåöèäèâîâ ñîêðàòèòñÿ, åñòü(ýòî ïîäòâåðæäåíî ðåçóëüòàòàìè èññëåäîâàíèé), ýòî âàæíî óæå äëÿ ðåáåíêà(âàæíûé ìîìåíò, óæå íå î ñåáå-îñ ñâîåì ñèëüíîì æåëàíèè, à î ðåáåêå ïîäóìàòü ñòîèò), äëÿ áåðåìåííîñòè, ïîòîìó ÷òî ðåöèäèâ âî âðåìÿ áåðåìåííîñòè ÃÃ-ýòî âñåãäà ðèñê äëÿ ðåáåíêà, ïîýòîìó íà ÷àùå âåñîâ åùå è: âîçìîæíîñòü ñîêðàòèòü ÷èñëî ðåöèäèâîâ âî âðåìÿ áåðåìåííîñòè äëÿ áåçîïàñíîñòè ðåáåíêà

ß ãîòîâà ñìåíèòü Âàëòðåêñ íà àöèêëîâèð, ïðîèçâîäèìûé [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
- ïî ïðåïàðàòó èññëåäîâàíèé áîëüøå, ñåé÷àñ ìîæíî îñòàâèòü è âàëòðåêñ, íî åñëè ïîòðåáóåòñÿ ïðèåì âî âðåìÿ áåðåìåííîñòè, àöèêëîâèð ìîæíî áóäåò èìåòü ââèäó
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 22.02.2011, 23:03
Àâàòàð äëÿ CuriousMasha
CuriousMasha CuriousMasha âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.03.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 29
Ñêàçàë(à) ñïàñèáî: 3
CuriousMasha *
Ñïàñèáî, Ìàðèÿ Þðüåâíà.
Ó ìåíÿ åùå îäèí âîïðîñ ïî ñóïðåññèâíîé òåðàïèè.
Ñëûøàëà, ÷òî â Èçðàèëå äëÿ ïîäãîòîâêè ê áåðåìåííîñòè æåíùèíàì ñ Ãà íàçíà÷àþò ýêïðåññ-ñóïðåññèþ ôàìâèðîì â òå÷åíèå 4 ìåñÿöåâ.
Ñóùåñòâóåò ëè òàêàÿ ñõåìà ïðîôèëàêòèêè ðåöèäèâîâ ïðè áåðåìåííîñòè?
Äåéñòâèòåëüíî ëè ôàìâèð ñèëüíåå âàëòðåêñà?
Åñëè äà, òî âîçìîæíî ãîä ñóïðåññèè âàëòðåêñîì ñîïîñòàâèì ïî ýôôåêòó ñ ÷åòûðåõìåñÿ÷íîé òåðàïèåé ôàìâèðîì?
Ìîæåò áûòü, ìíå ñòîèò ïåðåéòè íà ýòîò ïðåïàðàò, ÷òîáû íå îòêëàäûâàòü áåðåìåííîñòü ñëèøêîì íàäîëãî?
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 28.02.2011, 21:06
Dr.Anisimova Dr.Anisimova âíå ôîðóìà ÂÐÀ×
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 16.01.2007
Ãîðîä: ÐÔ
Ñîîáùåíèé: 14,319
Ñêàçàë(à) ñïàñèáî: 6
Ïîáëàãîäàðèëè 5,347 ðàç(à) çà 4,983 ñîîáùåíèé
Dr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Anisimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñëûøàëà, ÷òî â Èçðàèëå äëÿ ïîäãîòîâêè ê áåðåìåííîñòè æåíùèíàì ñ Ãà íàçíà÷àþò ýêïðåññ-ñóïðåññèþ ôàìâèðîì â òå÷åíèå 4 ìåñÿöåâ.
- ìîæíî ñêàçàòü, ÷òî ýòî ëó÷øå, ÷åì íè÷åãî êîíå÷íî; íî ôàêò îñòàåòñÿ ôàêòîì, ÷òî ñóïðåññèâíîé òåðàïèåé, êîãäà ìîæíî ñ÷èòàòü ïðîâåðåííûì â èññëåäîâàíèÿõ è äîñòîâåðíûì ïîñëå êóðñà òåðàïèè â 12 ìåñ. ñíèæåíèå âåðîÿòíîñòè ðåöèäèâà, òÿæåñòè ïðîÿâëåíèé ñ÷èòàåòñÿ èìåííî ãîä, êîãäà ìîæíî õîòÿ áû îöåíèâàòü ýôôåêò
Ñóùåñòâóåò ëè òàêàÿ ñõåìà ïðîôèëàêòèêè ðåöèäèâîâ ïðè áåðåìåííîñòè?
- óñëîâíî, ò.å. ñïåöèàëüíî òàêèõ ðåêîìåíäàöèé íèêòî íå âûäåëÿåò, ïîòîìó ÷òî áûâàåò î÷åíü ñëîæíî è æåíùèíå ñàìîé êîíòðîëèðîâàòü ñâîå æåëàíèå çàáåðåìåíåòü, òåì áîëåå ñïåöèàëèñòû íå â ñîñòîÿíèè ðåøèòü çà æåíùèíó, êîãäà åé ýòî äåëàòü
Äåéñòâèòåëüíî ëè ôàìâèð ñèëüíåå âàëòðåêñà?
- äàííûå ïîêà ÷òî î÷åíü îòíîñèòåëüíûå, â íåêîòîðûõ èññëåäîâàíèÿõ ðàçíèöà íåçíà÷èòåëüíà, ó÷èòûâàÿ äîçó, êðàòíîñòü ïðèåìà, ïîýòîìó íà÷èíàþò âñåãäà ñ àöèêëîâèðà, äàëåå, åñëè ýôôåêò íå óñòðàèâàåò, èñïîëüçóþò âàëàöèêëîâèð, ôàìâèð êàê àëüòåðíàòèâó
- â ëþáîì ñëó÷àå ñðàâíèòåëüíûå äàííûå ïî ýôôåêòèâíîñòè íèêàê íå îòðàæàþòñÿ íà ïðîäîëæèòåëüíîñòè ñóïðåññèâíîé òåðàïèè, òàêèõ è çàäà÷ â èññëåäîâàíèÿõ ïîêà ÷òî íå ñòîèò; ïðåïàðàòû ñðàâíèâàþòñÿ ïî ýôôåêòèâíîñòè ïîêà ÷òî ïðè ðàâíîì âðåìåíè ïðèåìà, ðàçíèöà íå òàê âåëèêà íà ñàìîì äåëå, êàê ýòî ÷àñòî ðåêëàìèðóåòñÿ
Åñëè äà, òî âîçìîæíî ãîä ñóïðåññèè âàëòðåêñîì ñîïîñòàâèì ïî ýôôåêòó ñ ÷åòûðåõìåñÿ÷íîé òåðàïèåé ôàìâèðîì?
- íåò, òàêèõ äàííûõ íåò òî÷íî, ôàìâèð íå òàê ñèëüíî îòëè÷àåòñÿ ïî ýôôåêòèâíîñòè, îäíî èç ãëàâíûõ îòëè÷èé â ïîëüçó-óäîáñòâî ïðèåìà/êðàòíîñòü ïðèåìà ïî ñðàâíåíèþ ñ àöèêëîâèðîì
Ìîæåò áûòü, ìíå ñòîèò ïåðåéòè íà ýòîò ïðåïàðàò, ÷òîáû íå îòêëàäûâàòü áåðåìåííîñòü ñëèøêîì íàäîëãî?
- îñîáîãî ñìûñëà â ýòîì íåò, ýòî íå ïîâëèÿåò è ñðîê íå ñîêðàòèò, ïðîáëåìà íå â âûáîðå ïðåïàðàòà, à ñêîëüêî Âû â ñîñòîÿíèè ñåáå äàòü âðåìåíè(ïñèõîýìîöèîíàëüíûé àñïåêò)- åñëè íå áîëåå 4 ìåñ., òî 4 ìåñ. òåðàïèè è åñòü åäèíñòâåííûé âàðèàíò, íî òîëüêî ïîòîìó, ÷òî ýòî ëó÷øå, ÷åì íè÷åãî
- êðóïíûå èññëåäîâàíèÿ ñðàâíèòåëüíûå(íå òàê ìíîãî ðàçëè÷èé, êàê êàæåòñÿ) ïî ïðîòèâîðåöèäèâíîé òåðàïèè:
- àöèêëîâèð/âàëàöèêëîâèð
• In one trial, 739 patients were randomly assigned to valacyclovir*(500 mg PO twice daily) or acyclovir*(200 mg PO five times daily) for five days at the time of the next recurrence [35]. There was no difference between the groups in the primary end point, which was the duration of all signs and symptoms, including lesion healing and pain and/or discomfort.
- ôàìöèêëîâèð/âàëàöèêëîâèð
• In a non-inferiority study of 1179 adults with a history of recurrent genital HSV, single-day famciclovir*(1000 mg twice daily) was compared with a three-day course of valacyclovir*(500 mg twice daily) [30]. Mean time to healing of lesions was similar in both groups and approximately one-third of patients in each treatment arm had aborted episodes. Both regimens were well tolerated. Viral shedding was not evaluated.
- ïî ñóïðåññèâíîé(ñîïîñòàâèìàÿ ýôôåêòèâíîñòü ïðåïàðàòîâ áåç ó÷åòà ñòîèìîñòè)
The relative efficacy of the available antiviral medications for suppression of genital herpes has been analyzed in a large meta-analysis of 6158 immunocompetent patients from 14 randomized placebo-controlled trials [22]. Compared with placebo, suppressive antiviral therapy lowered the relative risk of developing at least one recurrence (RR of 47 percent, 95% CI of 45-49 percent). This meta-analysis demonstrated comparable efficacy of acyclovir (400 mg twice daily), valacyclovir (250 mg twice daily), famciclovir (250 mg twice daily), or once-daily valacyclovir (500 mg). Limitations of this meta-analysis include heterogeneity of dosing regimens, varying rates of follow-up, and different methods for detection of shedding. Cost and potential long-term risks of chronic therapy were not addressed.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 01.03.2011, 22:12
Àâàòàð äëÿ CuriousMasha
CuriousMasha CuriousMasha âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.03.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 29
Ñêàçàë(à) ñïàñèáî: 3
CuriousMasha *
Ìàðèÿ Þðüåâíà, ÁÎËÜØÎÅ ÑÏÀÑÈÁÎ çà ñòîëü îáñòîÿòåëüíûé îòâåò!
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 14.10.2011, 15:03
Àâàòàð äëÿ CuriousMasha
CuriousMasha CuriousMasha âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 12.03.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 29
Ñêàçàë(à) ñïàñèáî: 3
CuriousMasha *
Óâàæàåìàÿ Ìàðèÿ Þðüåâíà, óâàæàåìûå äîêòîðà, âíîâü îáðàùàþñü ê âàì çà ïîìîùüþ. ß óæå ãîä ïüþ âàëöèêëîâèð â äîçå 500ìã â äåíü, äåëÿ åå íà 2 ïðèåìà â äåíü. Ðåöèäèâû, äåéñòâèòåëüíî, ñòàëè ñëó÷àòüñÿ ðåæå, íî âñå ýòî âðåìÿ ó ìåíÿ íå áûëî ñåêñà, òî åñòü íå áûëî ôàêòîðà ìåõàíè÷åñêîãî ðàçäðàæåíèÿ ïîðàæåííîé ñëèçèñòîé.

Íåäàâíî ó ìåíÿ ïîÿâèëñÿ ÷åëîâåê, êîòîðûì ÿ î÷åíü äîðîæó. Íî ïåðâûé æå ñåêñóàëüíûé êîíòàêò ïðèâåë ê îáîñòðåíèþ âàãèíàëüíîãî ãåðïåñà, õîòÿ çà òðè äíÿ äî íåãî ÿ äàæå óâåëè÷èëà äîçó âàëòðåêñà äî 1000 ìã â äåíü. Âòîðîé êîíòàêò áûë óæå î÷åíü áîëåçíåííûì èç-çà ìîèõ âûñûïàíèé (õîòÿ èõ è íåìíîãî, íî îíè ëîêàëèçîâàëèñü ïðÿìî ó âõîäà âî âëàãàëèùå), è ïðèøëîñü åãî ïðåêðàòèòü. Íàøè êîíòàêòû áûëè çàùèùåííûìè, ò.ê. ìîé ïàðòí¸ð çäîðîâ. Ìîæåò áûòü, ïîÿâèëèñü êàêèå-òî íîâûå ñõåìû ëå÷åíèÿ, âêëþ÷àÿ ìåñòíîå? Åùå õîòåëîñü áû óçíàòü, ñóùåñòâóþò ëè êàêèå-òî ìåòîäû, îáëåã÷àþùèå ñåêñóàëüíûé êîíòàêò, åñëè ÿ îáðå÷åíà íà ðåãóëÿðíûå ðåöèäèâû, îáóñëîâëåííûå áàíàëüíûì òðåíèåì? Ñëûøàëà, ÷òî ìî¸ ñîñòîÿíèå ìîæåò îáëåã÷èòü ñåêñ áåç ïðåçåðâàòèâà ñ íàçíà÷åíèåì ïàðòí¸ðó ïðè¸ìà âàëöèêëîâèðà êîðîòêèì êóðñîì, åñëè ïàðòíåð íà ýòî ñîãëàñèòñÿ? Ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 16:20.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.